Your Feed

Filter by
See content from
Back to the latest
Thumbnail for Fine Particulate Matter and Myeloma Outcomes in Urban Cohort | Michael Wysota, MD | ASH 2023
Playlist: ASH 2023

Fine Particulate Matter and Myeloma Outcomes in Urban Cohort | Michael Wysota, MD | ASH 2023

Video details & playlist
Thumbnail for Genomic Profiling in High-Risk Smoldering Myeloma | Benjamin Diamond, MD | ASH 2023
Playlist: ASH 2023

Genomic Profiling in High-Risk Smoldering Myeloma | Benjamin Diamond, MD | ASH 2023

Video details & playlist
Thumbnail for Dexamethasone Dose Strength Impact in Newly Diagnosed Myeloma | Rahul Banerjee, MD, FACP | ASH 2023
Playlist: ASH 2023

Dexamethasone Dose Strength Impact in Newly Diagnosed Myeloma | Rahul Banerjee, MD, FACP | ASH 2023

Video details & playlist
Thumbnail for CAR-T in Myeloma Patients with Extramedullary and Paramedullary Disease | Darren Pan, MD | ASH 2023
Playlist: ASH 2023

CAR-T in Myeloma Patients with Extramedullary and Paramedullary Disease | Darren Pan, MD | ASH 2023

Video details & playlist
Thumbnail for Real-World Patient Profile and Dosing of Teclistamab in Myeloma | Carlyn Rose Tan, MD | ASH 2023
Playlist: ASH 2023

Real-World Patient Profile and Dosing of Teclistamab in Myeloma | Carlyn Rose Tan, MD | ASH 2023

Video details & playlist
Thumbnail for Updates to Wearable Tech and Early Detection of CRS in Patients | Sridevi Rajeeve, MD | ASH 2023
Playlist: ASH 2023

Updates to Wearable Tech and Early Detection of CRS in Patients | Sridevi Rajeeve, MD | ASH 2023

Video details & playlist
Thumbnail for Real-World Results from Talquetamab and Bispecific Antibodies | Carolina Schinke, MD | ASH 2023
Playlist: ASH 2023

Real-World Results from Talquetamab and Bispecific Antibodies | Carolina Schinke, MD | ASH 2023

Video details & playlist
Thumbnail for Cost per Responder Analysis of Multiple Myeloma Patients | Doris K Hansen, MD | ASH 2023
Playlist: ASH 2023

Cost per Responder Analysis of Multiple Myeloma Patients | Doris K Hansen, MD | ASH 2023

Video details & playlist
Thumbnail for Links to Early Responses in Multiple Myeloma Patients | Doris K Hansen, MD | ASH 2023
Playlist: ASH 2023

Links to Early Responses in Multiple Myeloma Patients | Doris K Hansen, MD | ASH 2023

Video details & playlist
Thumbnail for Comparisons in Time to Next Treatment in Myeloma Patients | Doris K Hansen, MD | ASH 2023
Playlist: ASH 2023

Comparisons in Time to Next Treatment in Myeloma Patients | Doris K Hansen, MD | ASH 2023

Video details & playlist
Avatar
rubyCrocodile
Multiple Myeloma Discussion • December 8, 2023
Questions About Pre-SCT Lab Response
AI-generated title
Hello Everyone, I have a double hit high risk MM with 17P deletion and 1Q amplification. I am going thru induction therapy, 2nd line, switched to Isa-KRD last 2 cycles. Before that I was on Isa-VRD for 4 cycles and developed severe eye sties. My STEM cell transplant is expected to take place around Fed 2024. When I started my induction my free light chain Kappas were around 1950 mg/L and M protein was at 2.3 g/dL. I got a really good response intially after being on Velcade for 2 cycles. My free light chain Kappas decreased to 436 mg/L and M protein went down to 1.7 g/dL. The numbers plateaued after that for 2 cycles. The numbers increased when I was put off of Velcade for a month. Since starting new regimen with Kyprolis, the numbers fluctuated in both direction intially but now my ight chain Kappas are at 222 mg/L and M protein wis at 1.0 g/dL. The M protein is at 1.0 g/dL for the last 5 weeks. I am reaching out to you all with 3 questions: 1. Does my numbers look like they are improving as expected? 2. What were your numbers before SCT? 3. Are these numbers expected to be normalize before SCT? Thank you so much for your time!
Avatar
Marla
Multiple Myeloma Discussion • December 7, 2023
Cooling Caps for ASCT: Success Stories?
AI-generated title
Cooling caps for ASCT with Melphalan. Success stories? There is currently a clinical trial at Cedars Sinai that is having 100% success with 0-30% hair loss. Saving 70% hair or more. I'm going to City of Hope and can use the cooling cap, but they won't allow the Penguin representative to help me. Only my caregiver.
Avatar
TheNon
Multiple Myeloma Discussion • December 6, 2023
Sharing Experiences With Generic Lenalidomide?
AI-generated title
I'm grateful to be in remission with MM since transplant 18 months ago and have been taking maintenance Revlimid for 15 months. Medicare Plan D carriers have mostly stopped covering name brand and I'm asking if any of you would share experience with generic lenalidomide. I used a generic in January and was sick for a month and lost 5 lbs, so I've been hesitant to try it again but I may have to. Thanks for any input you can offer.
Avatar
grayDolphin
Multiple Myeloma Discussion • December 6, 2023
SCT Prep Questions: Line & Stopping Meds
AI-generated title
Husband set to go this month for SCT outpatient. Timeline has been laid out for us and collection should start next week. 2 questions: he was told today that he need NOT be accompanied for collection line insertion on Monday but will need someone to go with him when it is removed. Should I go anyway? Also, he has completed 4 cycles of induction therapy with little interruption to daily activities. Since stopping his treatment medications a week ago in pregnancy for SCT, he really feels lousy for the first time p, especially at night. Is this normal? Thanks.